The dermatology news sheet Dermatology Times has published an item to their web site about the emerging use of oxymetazoline to treat the redness and flushing associated with rosacea. This article draws from the Nov. 2007 paper that introduced us to the possibility of treating rosacea with oxymetazoline.
Oxymetazoline is classified as a alpha-1 Adregenic Receptor Agonist, whereas COL-118/Sansrosa is a alpha-2 Adregenic Receptor Agonist. According to this DT article oxymetazoline is “also partially selective for the alpha 2a receptor.”
(click to read more about oxymetazoline may be good for 2 years )
- Sansrosa’s sister to enter redness race
- oxymetazoline good for 6 hours and safe for 3 months
- Patents abound for treating rosacea with alpha agonists